UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 3 | March 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 6
June-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2106409


Registration ID:
310622

Page Number

d70-d78

Share This Article


Jetir RMS

Title

ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS

Abstract

Abstract INTRODUCTION First time on December 30, 2019, a report of a cluster of pneumonia of unknown aetiology was published on ProMED-mail, possibly related to contact with a seafood market in Wuhan, China. Following this till October 15, 2020, 38,394,169 confirmed cases of COVID-19, including 1,089,047 deaths have been reported to World Health Organization. First time, this case was reported on December 31, 2019 by WHO Country Office in China but based on symptoms; its beginning can be traced in initial days of December 2019. Initially for first few cases (n=29), this infection was classified as "pneumonia of unknown etiology." Following intensive outbreak investigation by the Chinese Center for Disease Control and Prevention (CDC) and local CDCs, this infection was classified as novel viral infection belonging to the coronavirus (CoV) family. Finally on February 11, 2020, the WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a "COVID-19," which is the acronym of "coronavirus disease 2019". This Coronaviruses are encapsulated, single-stranded RNA viruses that generally cause mild, cold-like illnesses in human beings and belongs to SARS-coronavirus-2 (SARS-CoV-2).Since December 2019, COVID-19 information has much evolved. Much information has been gathered about its transmission, symptomatology, diagnosis, treatment and prevention. Many clinical trials are undergoing regarding its vaccination. Along with this, many case reports have suggested about probable complications which arises during either the stage of illness or convalescence periods. These long-term effects of surviving COVID-19 have become a new focus of attention for clinicians and researchers.

Key Words

Keywords- Covid-19, Dyspnea, palpitation, respiration, angina pectoris, influenza

Cite This Article

"ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 6, page no.d70-d78, June-2021, Available :http://www.jetir.org/papers/JETIR2106409.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 6, page no. ppd70-d78, June-2021, Available at : http://www.jetir.org/papers/JETIR2106409.pdf

Publication Details

Published Paper ID: JETIR2106409
Registration ID: 310622
Published In: Volume 8 | Issue 6 | Year June-2021
DOI (Digital Object Identifier):
Page No: d70-d78
Country: Udaipur, Rajasthan, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000563

Print This Page

Current Call For Paper

Jetir RMS